Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-30 06:09:29 - browse：68365

Among the pharmaceutical companies’ many objections to the Biden administration’s drug pricing program is a set of provisions the industry says will warp how cancer drugs are developed. On Wednesday, AstraZeneca CEO Pascal Soriot proposed a new solution.

“What we were asking — and are asking now — is a very simple fix,” said Soriot at the STAT Future Summit, saying that “the impact on health care costs would be very marginal.”

The problem, executives say, is that companies developing cancer drugs today generally start small and then go big. They seek approval first in a small setting, such as patients who have exhausted all other therapies, where it’s easiest in terms of trial size and length to show a benefit. Then they go into larger settings, such as newly diagnosed patients, where studies take longer but the revenue potential is much higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Why CTE doesn’t keep Americans from enjoying the Super Bowl

WSS

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

UCSF medical school apologizes for unethical prisoner experiments

The Sacklers, horror, and ‘The Fall of the House of Usher’

Biotech incubator Curie.Bio graduates its first startup

AstraZeneca stays mum on Medicare drug pricing negotiations

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

knowledge

Wikipedia

hotspot

Drug repurposing or repositioning? The language matters

FDA approves Recor Medical high blood pressure device

At least 13 dead in Texas as scorching temps continue

The Biogen Aduhelm mess could happen again

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Cancer drug shortages should be causing more outrage

A clever new way to fix Medicaid and graduate medical education

focus

HPV cancer vaccine study demonstrates efficacy

A clever new way to fix Medicaid and graduate medical education

Medicare Advantage plans can’t deny care with AI, CMS warns

Unique patient identifier: Experts argue the benefits, pitfalls

Diversify hospital leadership teams to protect BIPOC patient health

Problems with a popular proposal to regulate AI in health care

hotspot

entertainment

knowledge

leisure time